首页 > 最新文献

Journal of Kidney Cancer and VHL最新文献

英文 中文
Incidence and Distribution of New Renal Cell Carcinoma Cases: 27-Year Trends from a Statewide Cancer Registry 新发肾细胞癌病例的发病率和分布:来自全国癌症登记的27年趋势
IF 1.6 Q3 ONCOLOGY Pub Date : 2022-04-18 DOI: 10.15586/jkcvhl.v9i2.219
Ahmad Alzubaidi, Stephen P Sekoulopoulos, J. Pham, Vonn Walter, Jay G. Fuletra, J. Raman
Nationwide databases have implicated an increased incidence of renal cell carcinoma (RCC). The Pennsylvania (PA) Cancer Registry was queried to better define incidence, geographic distribution, and statewide trends of new RCC cases over a 27-year period. JoinPoint Trend Analysis Software modeled average annual percent changes (APCs) in age-adjusted rates (AAR). Maps plotting county-level incidence rates and stage distribution of disease across the state in 5-year time intervals were created using R 4.0.2 software. Overall, 59,628 cases of RCC were recorded in PA from 1990 to 2017. Eighty six percent of patients were >50 years of age, 61% were males, and 89% were Caucasian. Stage distribution using the SEER staging system included 64% local, 17% regional, and 16% distant. Over the study interval, AAR of all RCC cases increased from 9.9 to 18.0 patients per 100,000 population with an APC of 2.3% (p < 0.01). AAR of local disease increased from 5.4 to 12.7 patients per 100,000 population with an APC of 3.2% (p < 0.01). AAR of regional disease also increased from 1.9 to 2.9 patients per 100,000 population with an APC of 1.0% (p = 0.01). Younger patients (<50 years) had a greater rate of increase than older counterparts (APC 3.8% vs. 2.0%, p < 0.05). Geospatial investigation of new RCC cases noted certain geographic concentrations of greater disease incidence. The incidence of RCC in PA has increased over the past 27 years in PA. One-third of the cases are regional or metastatic at presentation and rates of increase were most notable in younger patients.
全国范围内的数据库显示,肾细胞癌(RCC)的发病率有所增加。对宾夕法尼亚州(PA)癌症登记处进行了查询,以更好地定义27年来新发RCC病例的发病率、地理分布和全州趋势。JoinPoint趋势分析软件对年龄调整率(AAR)的年均百分比变化(apc)进行了建模。使用r4.0.2软件绘制了5年时间间隔内全州县级发病率和疾病阶段分布的地图。总体而言,从1990年到2017年,PA记录了59,628例RCC病例。86%的患者年龄在50岁至50岁之间,61%为男性,89%为高加索人。使用SEER分期系统的分期分布包括64%的本地,17%的区域和16%的远程。在研究期间,所有RCC病例的AAR从每10万人9.9例增加到18.0例,APC为2.3% (p < 0.01)。局部疾病的AAR从每10万人5.4例增加到12.7例,APC为3.2% (p < 0.01)。区域疾病的AAR也从每10万人1.9例增加到2.9例,APC为1.0% (p = 0.01)。年轻患者(<50岁)的APC增加率高于老年患者(APC 3.8%比2.0%,p < 0.05)。对新发RCC病例的地理空间调查发现,某些疾病发病率较高的地理集中区域。在过去的27年里,肾小球癌的发病率有所增加。三分之一的病例在发病时是区域性或转移性的,年轻患者的发病率增加最为显著。
{"title":"Incidence and Distribution of New Renal Cell Carcinoma Cases: 27-Year Trends from a Statewide Cancer Registry","authors":"Ahmad Alzubaidi, Stephen P Sekoulopoulos, J. Pham, Vonn Walter, Jay G. Fuletra, J. Raman","doi":"10.15586/jkcvhl.v9i2.219","DOIUrl":"https://doi.org/10.15586/jkcvhl.v9i2.219","url":null,"abstract":"Nationwide databases have implicated an increased incidence of renal cell carcinoma (RCC). The Pennsylvania (PA) Cancer Registry was queried to better define incidence, geographic distribution, and statewide trends of new RCC cases over a 27-year period. JoinPoint Trend Analysis Software modeled average annual percent changes (APCs) in age-adjusted rates (AAR). Maps plotting county-level incidence rates and stage distribution of disease across the state in 5-year time intervals were created using R 4.0.2 software. Overall, 59,628 cases of RCC were recorded in PA from 1990 to 2017. Eighty six percent of patients were >50 years of age, 61% were males, and 89% were Caucasian. Stage distribution using the SEER staging system included 64% local, 17% regional, and 16% distant. Over the study interval, AAR of all RCC cases increased from 9.9 to 18.0 patients per 100,000 population with an APC of 2.3% (p < 0.01). AAR of local disease increased from 5.4 to 12.7 patients per 100,000 population with an APC of 3.2% (p < 0.01). AAR of regional disease also increased from 1.9 to 2.9 patients per 100,000 population with an APC of 1.0% (p = 0.01). Younger patients (<50 years) had a greater rate of increase than older counterparts (APC 3.8% vs. 2.0%, p < 0.05). Geospatial investigation of new RCC cases noted certain geographic concentrations of greater disease incidence. The incidence of RCC in PA has increased over the past 27 years in PA. One-third of the cases are regional or metastatic at presentation and rates of increase were most notable in younger patients.","PeriodicalId":44291,"journal":{"name":"Journal of Kidney Cancer and VHL","volume":"9 1","pages":"7 - 12"},"PeriodicalIF":1.6,"publicationDate":"2022-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43355062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma 肾细胞癌中高水平的PD-L1+和Hyal2+髓源性抑制细胞
IF 1.6 Q3 ONCOLOGY Pub Date : 2022-04-16 DOI: 10.15586/jkcvhl.v9i2.208
S. Kusmartsev, Elizabeth P. Kwenda, Paul R. Dominguez-Gutierrez, P. Crispen, P. O'Malley
Renal cell carcinoma (RCC) patients frequently have increased number of immunosuppressive myeloid cells in circulation. High number of myeloid-derived suppressor cells (MDSCs) in the blood are associated with immune suppression as well as with cancer-related inflammation which drives the mobilization of myeloid cells to tumor tissue. Here, we show that peripheral blood from a previously untreated RCC patient has increased the number of monocytic CD33+CD11b+ MDSCs, which also co-expressed PD-L1 and membrane-bound enzyme hyaluronidase 2 (Hyal2). PD-L1 expression is associated with immune suppression, whereas expression of Hyal2 is associated with inflammation, because Hyal2+ myeloid cells can degrade the extracellular hyaluronan (HA), leading to the accumulation of pro-inflammatory HA fragments with low molecular weight. These findings implicate the potential involvement of monocytic MDSCs in both tumor-associated immune suppression and cancer-related inflammation. Analysis of organotypic tumor-tissue slice cultures prepared from cancer tissue of the same patient revealed the significant presence of PD-L1+ HLA-DR+ macrophage-like or dendritic cell-like antigen-presenting cells in tumor stroma. Interestingly, stroma-associated PD-L1+ cells frequently have intracellular hyaluronan. Collectively, data presented in this study suggest that the interplay between tumor-recruited myeloid cells and stromal HA may contribute to the inflammation and immune tolerance in kidney cancer.
肾细胞癌(RCC)患者循环中免疫抑制性骨髓细胞的数量经常增加。血液中大量的骨髓源性抑制细胞(MDSC)与免疫抑制以及癌症相关炎症有关,癌症相关炎症驱动骨髓细胞动员到肿瘤组织。在这里,我们发现来自先前未经治疗的RCC患者的外周血增加了单核细胞CD33+CD11b+MDSCs的数量,其也共表达PD-L1和膜结合酶透明质酸酶2(Hyal2)。PD-L1的表达与免疫抑制有关,而Hyal2的表达与炎症有关,因为Hyal2+髓系细胞可以降解细胞外透明质酸(HA),导致低分子量的促炎性HA片段的积累。这些发现暗示了单核细胞MDSC在肿瘤相关免疫抑制和癌症相关炎症中的潜在参与。对从同一患者的癌症组织制备的器官型肿瘤组织切片培养物的分析显示,在肿瘤间质中显著存在PD-L1+HLA-DR+巨噬细胞样或树突状细胞样抗原呈递细胞。有趣的是,基质相关的PD-L1+细胞经常具有细胞内透明质酸。总之,本研究中提供的数据表明,肿瘤募集的髓细胞和基质HA之间的相互作用可能有助于癌症的炎症和免疫耐受。
{"title":"High Levels of PD-L1+ and Hyal2+ Myeloid-derived Suppressor Cells in Renal Cell Carcinoma","authors":"S. Kusmartsev, Elizabeth P. Kwenda, Paul R. Dominguez-Gutierrez, P. Crispen, P. O'Malley","doi":"10.15586/jkcvhl.v9i2.208","DOIUrl":"https://doi.org/10.15586/jkcvhl.v9i2.208","url":null,"abstract":"Renal cell carcinoma (RCC) patients frequently have increased number of immunosuppressive myeloid cells in circulation. High number of myeloid-derived suppressor cells (MDSCs) in the blood are associated with immune suppression as well as with cancer-related inflammation which drives the mobilization of myeloid cells to tumor tissue. Here, we show that peripheral blood from a previously untreated RCC patient has increased the number of monocytic CD33+CD11b+ MDSCs, which also co-expressed PD-L1 and membrane-bound enzyme hyaluronidase 2 (Hyal2). PD-L1 expression is associated with immune suppression, whereas expression of Hyal2 is associated with inflammation, because Hyal2+ myeloid cells can degrade the extracellular hyaluronan (HA), leading to the accumulation of pro-inflammatory HA fragments with low molecular weight. These findings implicate the potential involvement of monocytic MDSCs in both tumor-associated immune suppression and cancer-related inflammation. Analysis of organotypic tumor-tissue slice cultures prepared from cancer tissue of the same patient revealed the significant presence of PD-L1+ HLA-DR+ macrophage-like or dendritic cell-like antigen-presenting cells in tumor stroma. Interestingly, stroma-associated PD-L1+ cells frequently have intracellular hyaluronan. Collectively, data presented in this study suggest that the interplay between tumor-recruited myeloid cells and stromal HA may contribute to the inflammation and immune tolerance in kidney cancer.","PeriodicalId":44291,"journal":{"name":"Journal of Kidney Cancer and VHL","volume":"9 1","pages":"1 - 6"},"PeriodicalIF":1.6,"publicationDate":"2022-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46108715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Primary Rhabdomyosarcoma of Kidney with Local Recurrence and Liver Metastasis in Adults: A Case Report 成人原发性肾横纹肌肉瘤伴局部复发及肝转移1例报告
IF 1.6 Q3 ONCOLOGY Pub Date : 2022-04-14 DOI: 10.15586/jkcvhl.v9i1.218
H. Nasrollahi, Ali Eslahi, Ali Ariafar, F. Ahmed, A. Monabati
Primary rhabdomyosarcoma (RMS) of the kidney in an adult is rare, with only a few cases published in the literature. It is a mesenchymal tumor associated with an aggressive and rapid clinical progression course. We present a case of primary renal RMS in a 58-year-old female who presented with intermittent abdominal pain in the past year. The computed tomography (CT) scan revealed a 20×25×8 cm heterogeneous solid mass in the middle pole extended to the lower pole of the right kidney. Therefore, the patient underwent a right radical nephroureterectomy. Histopathology examination and immunohistochemistry studies confirmed the diagnosis of RMS with pleomorphic components. Postoperatively, the patient was discharged without any complications and was referred to an oncologist for chemotherapy. However, a follow-up CT scan in 2 months showed widespread liver metastasis and local recurrence. The patient received Gemcitabine and Docetaxel, but her condition worsened, and she passed away 5 months later. Primary renal RMS is rare in adults. In addition, liver metastasis is uncommon and poorly understood. Hence, we describe the clinicopathologic characteristics, including clinical follow-up of our case, focusing on the disease progression, treatment, and outcome.
原发性肾横纹肌肉瘤(RMS)在成人中是罕见的,只有少数病例在文献中发表。它是一种具有侵袭性和快速临床进展过程的间充质肿瘤。我们提出了一个58岁的女性原发性肾RMS病例,她在过去的一年里出现了间歇性腹痛。计算机断层扫描(CT)显示一个20×25×8厘米的不均匀实性肿块,在中极延伸到右肾下极。因此,患者接受了右侧肾输尿管根治术。组织病理学检查和免疫组织化学研究证实了RMS具有多形性成分的诊断。术后,患者出院,无任何并发症,并被转介到肿瘤科医生化疗。然而,2个月的随访CT扫描显示广泛的肝转移和局部复发。患者接受吉西他滨和多西他赛治疗,但病情恶化,5个月后去世。原发性肾RMS在成人中很少见。此外,肝转移并不常见,对其了解甚少。因此,我们描述了临床病理特征,包括我们病例的临床随访,重点是疾病进展,治疗和结果。
{"title":"Primary Rhabdomyosarcoma of Kidney with Local Recurrence and Liver Metastasis in Adults: A Case Report","authors":"H. Nasrollahi, Ali Eslahi, Ali Ariafar, F. Ahmed, A. Monabati","doi":"10.15586/jkcvhl.v9i1.218","DOIUrl":"https://doi.org/10.15586/jkcvhl.v9i1.218","url":null,"abstract":"Primary rhabdomyosarcoma (RMS) of the kidney in an adult is rare, with only a few cases published in the literature. It is a mesenchymal tumor associated with an aggressive and rapid clinical progression course. We present a case of primary renal RMS in a 58-year-old female who presented with intermittent abdominal pain in the past year. The computed tomography (CT) scan revealed a 20×25×8 cm heterogeneous solid mass in the middle pole extended to the lower pole of the right kidney. Therefore, the patient underwent a right radical nephroureterectomy. Histopathology examination and immunohistochemistry studies confirmed the diagnosis of RMS with pleomorphic components. Postoperatively, the patient was discharged without any complications and was referred to an oncologist for chemotherapy. However, a follow-up CT scan in 2 months showed widespread liver metastasis and local recurrence. The patient received Gemcitabine and Docetaxel, but her condition worsened, and she passed away 5 months later. Primary renal RMS is rare in adults. In addition, liver metastasis is uncommon and poorly understood. Hence, we describe the clinicopathologic characteristics, including clinical follow-up of our case, focusing on the disease progression, treatment, and outcome.","PeriodicalId":44291,"journal":{"name":"Journal of Kidney Cancer and VHL","volume":"9 1","pages":"55 - 58"},"PeriodicalIF":1.6,"publicationDate":"2022-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67104234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Renal Leiomyosarcoma, a Rare Presentation 肾脏平滑肌肉瘤,一种罕见的表现
IF 1.6 Q3 ONCOLOGY Pub Date : 2022-03-21 DOI: 10.15586/jkcvhl.v9i1.216
T. Djiwa, K. Sabi, P. Simgban, Mayi Bombonne, B. Sama, Mazamaesso Tchaou, T. Darré
Renal sarcomas are very rare malignant tumours with a very poor prognosis. Renal leiomyosarcoma, a malignant tumour of smooth muscle origin, is the most common histological type. The article reports a case of leiomyosarcoma of renal location, with a review of the literature. A 38-year-old female patient, with no previous pathological history, consulted the nephrology department of the Teaching Hospital of Lomé for abdominal pain that had been present for 4 years. Histology showed a tumour proliferation of fasciculated architecture, made of spindle cells arranged in long bundles, with cytonuclear atypia and cytoarchitectural abnormalities. Immunohistochemical examination showed positive staining for smooth muscle actin, h-caldesmone, desmin and CD34 and negative for pancytokeratin (AE1/AE3), myogenin and PS100. Renal leiomyosarcoma is an exceptional malignancy. It remains the most common renal sarcoma, the differential diagnosis of which is based on immunohistochemical findings.
肾肉瘤是一种非常罕见的恶性肿瘤,预后很差。肾平滑肌肉瘤是一种起源于平滑肌的恶性肿瘤,是最常见的组织学类型。本文报告1例肾脏部位平滑肌肉瘤,并复习文献。38岁女性患者,既往无病理史,因腹痛4年就诊lomoise教学医院肾脏病科。组织学显示肿瘤呈束状结构增生,由长束排列的梭形细胞组成,具有细胞核异型性和细胞结构异常。免疫组化检查显示平滑肌肌动蛋白、h- caldesmoone、desmin和CD34阳性,全细胞角蛋白(AE1/AE3)、肌原蛋白和PS100阴性。肾平滑肌肉瘤是一种罕见的恶性肿瘤。它仍然是最常见的肾肉瘤,其鉴别诊断是基于免疫组织化学结果。
{"title":"Renal Leiomyosarcoma, a Rare Presentation","authors":"T. Djiwa, K. Sabi, P. Simgban, Mayi Bombonne, B. Sama, Mazamaesso Tchaou, T. Darré","doi":"10.15586/jkcvhl.v9i1.216","DOIUrl":"https://doi.org/10.15586/jkcvhl.v9i1.216","url":null,"abstract":"Renal sarcomas are very rare malignant tumours with a very poor prognosis. Renal leiomyosarcoma, a malignant tumour of smooth muscle origin, is the most common histological type. The article reports a case of leiomyosarcoma of renal location, with a review of the literature. A 38-year-old female patient, with no previous pathological history, consulted the nephrology department of the Teaching Hospital of Lomé for abdominal pain that had been present for 4 years. Histology showed a tumour proliferation of fasciculated architecture, made of spindle cells arranged in long bundles, with cytonuclear atypia and cytoarchitectural abnormalities. Immunohistochemical examination showed positive staining for smooth muscle actin, h-caldesmone, desmin and CD34 and negative for pancytokeratin (AE1/AE3), myogenin and PS100. Renal leiomyosarcoma is an exceptional malignancy. It remains the most common renal sarcoma, the differential diagnosis of which is based on immunohistochemical findings.","PeriodicalId":44291,"journal":{"name":"Journal of Kidney Cancer and VHL","volume":"9 1","pages":"51 - 54"},"PeriodicalIF":1.6,"publicationDate":"2022-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42624965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Inflammatory Hibernoma of the Renal Hilum Mimicking a Renal Pelvis Tumor 类似肾盂肿瘤的肾门炎性冬眠瘤
IF 1.6 Q3 ONCOLOGY Pub Date : 2022-03-16 DOI: 10.15586/jkcvhl.v9i1.225
Kelsey Larkin, Kevin J. Chua, S. Doppalapudi, Colton Smith, Evita T. Sadimin, V. Fitzhugh, E. Singer
We report on an enhancing, heterogenous renal pelvis mass growing over 2 years which was found to be a benign hibernoma with inflammatory and lipomatous features originating from the renal hilum. To our knowledge, this is the first case reported on a hibernoma compressing on the renal pelvis and second case of a hibernoma with the inflammatory variant.
我们报告一个生长超过2年的增强的异质肾盂肿块,被发现是一种良性冬眠瘤,具有起源于肾门的炎症和脂肪瘤特征。据我们所知,这是第一例报告的压迫肾盂的冬眠瘤和第二例伴有炎症变异体的冬眠瘤。
{"title":"Inflammatory Hibernoma of the Renal Hilum Mimicking a Renal Pelvis Tumor","authors":"Kelsey Larkin, Kevin J. Chua, S. Doppalapudi, Colton Smith, Evita T. Sadimin, V. Fitzhugh, E. Singer","doi":"10.15586/jkcvhl.v9i1.225","DOIUrl":"https://doi.org/10.15586/jkcvhl.v9i1.225","url":null,"abstract":"We report on an enhancing, heterogenous renal pelvis mass growing over 2 years which was found to be a benign hibernoma with inflammatory and lipomatous features originating from the renal hilum. To our knowledge, this is the first case reported on a hibernoma compressing on the renal pelvis and second case of a hibernoma with the inflammatory variant.","PeriodicalId":44291,"journal":{"name":"Journal of Kidney Cancer and VHL","volume":"9 1","pages":"48 - 50"},"PeriodicalIF":1.6,"publicationDate":"2022-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67104278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spectrum of Presentations and Management Strategies in Renal Angiomyolipoma. 肾血管肌脂肪瘤的表现范围和处理策略
IF 1.6 Q3 ONCOLOGY Pub Date : 2022-01-28 eCollection Date: 2022-01-01 DOI: 10.15586/jkcvhl.v9i1.221
Sinan Khaddam, Shuchi Gulati

Renal angiomyolipoma (rAML) occurs rarely sporadically but is commonly encountered in patients with tuberous sclerosis complex and lymphangioleiomyomatosis. rAML is a rare entity, not seen regularly in daily practice; however, is commonly encountered and diagnosed by clinicians who approach and treat kidney masses. Basic knowledge of this entity is necessary to recognize that despite being benign, these tumors can rarely cause deadly complications such as hemorrhage or severe renal dysfunction or may have malignant components associated with them.

肾血管肌脂肪瘤(rAML)很少偶发,但常见于结节性硬化症复合体和淋巴管瘤病患者。rAML 是一种罕见的肿瘤,在日常诊疗中并不常见,但临床医生在处理和治疗肾脏肿块时经常会遇到并诊断出这种肿瘤。要认识到这些肿瘤尽管是良性的,但在极少数情况下会引起致命的并发症,如出血或严重的肾功能障碍,或可能伴有恶性成分,就必须对这种肿瘤有基本的了解。
{"title":"Spectrum of Presentations and Management Strategies in Renal Angiomyolipoma.","authors":"Sinan Khaddam, Shuchi Gulati","doi":"10.15586/jkcvhl.v9i1.221","DOIUrl":"10.15586/jkcvhl.v9i1.221","url":null,"abstract":"<p><p>Renal angiomyolipoma (rAML) occurs rarely sporadically but is commonly encountered in patients with tuberous sclerosis complex and lymphangioleiomyomatosis. rAML is a rare entity, not seen regularly in daily practice; however, is commonly encountered and diagnosed by clinicians who approach and treat kidney masses. Basic knowledge of this entity is necessary to recognize that despite being benign, these tumors can rarely cause deadly complications such as hemorrhage or severe renal dysfunction or may have malignant components associated with them.</p>","PeriodicalId":44291,"journal":{"name":"Journal of Kidney Cancer and VHL","volume":"9 1","pages":"42-47"},"PeriodicalIF":1.6,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808295/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39894413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Trends and Evidence for the Management of Renal Angiomyolipoma: A Comprehensive Narrative Review of the Literature. 肾血管平滑肌脂肪瘤治疗的新趋势和新证据:文献综述。
IF 1.6 Q3 ONCOLOGY Pub Date : 2022-01-21 eCollection Date: 2022-01-01 DOI: 10.15586/jkcvhl.v9i1.177
Juan Camilo Álvarez Restrepo, David Andres Castañeda Millan, Carlos Andres Riveros Sabogal, Andres Felipe Puentes Bernal, Wilfredo Donoso Donoso
Treatment of renal angiomyolipoma (AML) seeks to reduce related complications and preserve kidney function. The purpose of this article was to perform an updated literature review on the diagnosis, therapeutic options, and criteria for invasive intervention in patients with renal AML. Computerized tomography is the standard diagnostic method for renal AML, while definitive diagnosis is made by histopathology. The management of choice in most cases is active surveillance (AS), with a clinical and imaging follow-up protocol. In high-risk cases, therapeutic management should be considered, with alternatives such as selective arterial embolization (SAE), nephron-sparing surgery (NSS), and mTOR inhibitors in selected patients. Renal AML in women of childbearing age, those with growth >0.25 cm/year, intralesional aneurysms >5 mm, and clinically significant symptoms may qualify for active treatment. Despite the limitations derived from the available evidence, it is possible to consider SAE, NSS, and the use of mTOR inhibitors as management alternatives for selected patients.
肾血管平滑肌脂肪瘤(AML)的治疗旨在减少相关并发症和保持肾功能。本文的目的是对肾性急性髓性白血病患者的诊断、治疗选择和侵入性干预标准进行最新的文献综述。计算机断层扫描是肾性急性髓性白血病的标准诊断方法,而明确的诊断是通过组织病理学。在大多数情况下,选择的管理是主动监测(AS),并有临床和影像学随访协议。在高危病例中,应考虑治疗性管理,选择选择性动脉栓塞(SAE)、保留肾元手术(NSS)和mTOR抑制剂等替代方案。育龄妇女肾性AML,生长>0.25 cm/年,瘤内动脉瘤> 5mm,临床症状显著者可能有资格接受积极治疗。尽管现有证据存在局限性,但可以考虑将SAE、NSS和mTOR抑制剂作为选定患者的管理选择。
{"title":"New Trends and Evidence for the Management of Renal Angiomyolipoma: A Comprehensive Narrative Review of the Literature.","authors":"Juan Camilo Álvarez Restrepo,&nbsp;David Andres Castañeda Millan,&nbsp;Carlos Andres Riveros Sabogal,&nbsp;Andres Felipe Puentes Bernal,&nbsp;Wilfredo Donoso Donoso","doi":"10.15586/jkcvhl.v9i1.177","DOIUrl":"https://doi.org/10.15586/jkcvhl.v9i1.177","url":null,"abstract":"Treatment of renal angiomyolipoma (AML) seeks to reduce related complications and preserve kidney function. The purpose of this article was to perform an updated literature review on the diagnosis, therapeutic options, and criteria for invasive intervention in patients with renal AML. Computerized tomography is the standard diagnostic method for renal AML, while definitive diagnosis is made by histopathology. The management of choice in most cases is active surveillance (AS), with a clinical and imaging follow-up protocol. In high-risk cases, therapeutic management should be considered, with alternatives such as selective arterial embolization (SAE), nephron-sparing surgery (NSS), and mTOR inhibitors in selected patients. Renal AML in women of childbearing age, those with growth >0.25 cm/year, intralesional aneurysms >5 mm, and clinically significant symptoms may qualify for active treatment. Despite the limitations derived from the available evidence, it is possible to consider SAE, NSS, and the use of mTOR inhibitors as management alternatives for selected patients.","PeriodicalId":44291,"journal":{"name":"Journal of Kidney Cancer and VHL","volume":"9 1","pages":"33-41"},"PeriodicalIF":1.6,"publicationDate":"2022-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39962019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Inflammatory Myofibroblastic Tumor of the Right Kidney Mimicking a Locally Advanced Renal Carcinoma: A Case Report. 模拟局部晚期肾癌的右肾炎性肌纤维母细胞瘤1例。
IF 1.6 Q3 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.15586/jkcvhl.v9i4.238
Ali Ariafar, Faisal Ahmed, AbdolAzim Khorshidi, Simin Torabi-Nezhad, Seyed Hossein Hosseini
An inflammatory myofibroblastic tumor (IMT) is a rare neoplasm with an unclear origin that can arise anywhere on the body. It contains spindle cells (myofibroblasts) with different inflammatory elements. Primary IMT of the kidney is a clinically rare disease and is difficult to differentiate from other renal malignancies. We reported a 49-year-old male who presented with right flank pain in the past year. A computed tomography scan showed a mixed density with slight heterogeneous enhancement mass in the upper pole of the right kidney, two small hypodense nodules invading the liver, and another mass in the lateral aspect of inferior vena cava. The patient underwent right radical nephrectomy and metastasectomy. IMT was confirmed by both postoperative histopathological examination and immunohistochemical assay. The patient recovered well after the operation, and no recurrence or metastasis was noted during the 12-month follow-up.
炎症性肌纤维母细胞瘤是一种罕见的肿瘤,起源不明,可发生在身体的任何部位。它含有梭形细胞(肌成纤维细胞),具有不同的炎症因子。原发性肾脏IMT是临床上罕见的疾病,很难与其他肾脏恶性肿瘤鉴别。我们报告了一名49岁的男性,他在过去的一年里出现了右侧疼痛。计算机断层扫描显示右肾上极有轻度不均匀强化的混合密度肿块,两个小的低密度结节侵入肝脏,下腔静脉外侧有另一个肿块。患者行右侧根治性肾切除术及转移性肾切除术。术后组织病理学检查和免疫组织化学检测均证实为IMT。患者术后恢复良好,随访12个月无复发或转移。
{"title":"Inflammatory Myofibroblastic Tumor of the Right Kidney Mimicking a Locally Advanced Renal Carcinoma: A Case Report.","authors":"Ali Ariafar,&nbsp;Faisal Ahmed,&nbsp;AbdolAzim Khorshidi,&nbsp;Simin Torabi-Nezhad,&nbsp;Seyed Hossein Hosseini","doi":"10.15586/jkcvhl.v9i4.238","DOIUrl":"https://doi.org/10.15586/jkcvhl.v9i4.238","url":null,"abstract":"An inflammatory myofibroblastic tumor (IMT) is a rare neoplasm with an unclear origin that can arise anywhere on the body. It contains spindle cells (myofibroblasts) with different inflammatory elements. Primary IMT of the kidney is a clinically rare disease and is difficult to differentiate from other renal malignancies. We reported a 49-year-old male who presented with right flank pain in the past year. A computed tomography scan showed a mixed density with slight heterogeneous enhancement mass in the upper pole of the right kidney, two small hypodense nodules invading the liver, and another mass in the lateral aspect of inferior vena cava. The patient underwent right radical nephrectomy and metastasectomy. IMT was confirmed by both postoperative histopathological examination and immunohistochemical assay. The patient recovered well after the operation, and no recurrence or metastasis was noted during the 12-month follow-up.","PeriodicalId":44291,"journal":{"name":"Journal of Kidney Cancer and VHL","volume":"9 4","pages":"14-18"},"PeriodicalIF":1.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10452828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Primary Chondrosarcoma in L-shaped Crossed Fused Renal Ectopia Coexisting with Papillary Urothelial Carcinoma in Urinary Bladder - An Enigmatic Entity with Poor Prognosis. l型交叉融合肾异位的原发性软骨肉瘤与膀胱乳头状尿路上皮癌共存-一种预后不良的神秘实体。
IF 1.6 Q3 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.15586/jkcvhl.v9i1.162
Mayank Kumar, Aasma Nalwa, Taruna Yadav, Poonam Elhence, Himanshu Pandey, Meenakshi Rao

Primary renal chondrosarcomas are rare tumors that are high-grade in nature and, unfortunately, have poorly understood pathogenesis and extremely low prognosis. The coexistence of a discrete malignancy in the urinary bladder is even rarer, with the occurrence of distinct papillary urothelial carcinoma in the urinary bladder in this case. The clinical presentation is nonspecific, and the primary radiological investigations have a limited scope in providing specific diagnosis of this entity. The final diagnosis is possible on thorough histopathological examination of the resected specimen, which requires extensive sampling and meticulous reporting. As of now, the only way to achieve a better prognosis is by early diagnosis. It is necessary to keep the possibility of occurrence of sarcomas at rare sites in the differential diagnoses. The cytogenetic and molecular abnormalities associated with this entity need to be elucidated to achieve a more satisfactory outcome concerning the overall management of the patient.

原发性肾软骨肉瘤是一种罕见的高级别肿瘤,不幸的是,其发病机制尚不清楚,预后极低。单独的恶性肿瘤在膀胱中共存的情况更罕见,在本病例中,膀胱中出现明显的乳头状尿路上皮癌。临床表现是非特异性的,主要的放射学检查在提供这种实体的具体诊断方面具有有限的范围。最终诊断是可能的彻底的组织病理学检查切除标本,这需要广泛的抽样和细致的报告。到目前为止,获得更好预后的唯一方法是早期诊断。在鉴别诊断时,应注意罕见部位发生肉瘤的可能性。需要阐明与该实体相关的细胞遗传学和分子异常,以便在患者的整体管理方面取得更令人满意的结果。
{"title":"Primary Chondrosarcoma in L-shaped Crossed Fused Renal Ectopia Coexisting with Papillary Urothelial Carcinoma in Urinary Bladder - An Enigmatic Entity with Poor Prognosis.","authors":"Mayank Kumar,&nbsp;Aasma Nalwa,&nbsp;Taruna Yadav,&nbsp;Poonam Elhence,&nbsp;Himanshu Pandey,&nbsp;Meenakshi Rao","doi":"10.15586/jkcvhl.v9i1.162","DOIUrl":"https://doi.org/10.15586/jkcvhl.v9i1.162","url":null,"abstract":"<p><p>Primary renal chondrosarcomas are rare tumors that are high-grade in nature and, unfortunately, have poorly understood pathogenesis and extremely low prognosis. The coexistence of a discrete malignancy in the urinary bladder is even rarer, with the occurrence of distinct papillary urothelial carcinoma in the urinary bladder in this case. The clinical presentation is nonspecific, and the primary radiological investigations have a limited scope in providing specific diagnosis of this entity. The final diagnosis is possible on thorough histopathological examination of the resected specimen, which requires extensive sampling and meticulous reporting. As of now, the only way to achieve a better prognosis is by early diagnosis. It is necessary to keep the possibility of occurrence of sarcomas at rare sites in the differential diagnoses. The cytogenetic and molecular abnormalities associated with this entity need to be elucidated to achieve a more satisfactory outcome concerning the overall management of the patient.</p>","PeriodicalId":44291,"journal":{"name":"Journal of Kidney Cancer and VHL","volume":"9 1","pages":"9-14"},"PeriodicalIF":1.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39781604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Resolution Ultrasonography of Renal Oncocytoma Presenting with Symptomatic Hematuria and Urinary Bladder Clot Retention-A Rare Occurrence. 以症状性血尿和膀胱血栓潴留为表现的肾嗜瘤瘤的高分辨率超声检查——罕见的病例。
IF 1.6 Q3 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.15586/jkcvhl.v9i1.200
Reddy Ravikanth

Renal oncocytomas are asymptomatic, benign tumors often encountered incidentally on various imaging modalities. Renal oncocytomas comprise 5-7% of primary renal neoplasms and are derived from cells of the distal renal tubule. We present a case report of renal oncocytoma in a 22-year-old male having right-sided flank pain and symptomatic gross hematuria with a giant urinary bladder clot retention. The tumor was excised, and the patient underwent laparoscopic partial nephrectomy. Typical features of renal oncocytoma were observed upon histopathological examination of the resected specimen. The patient was catheterized, and bladder irrigation with clot retraction was performed.

肾嗜瘤细胞瘤是一种无症状的良性肿瘤,经常在各种影像学检查中偶然发现。肾癌细胞瘤占原发性肾肿瘤的5-7%,起源于远端肾小管细胞。我们报告一例22岁男性肾嗜酸细胞瘤患者,有右侧腹部疼痛和明显的血尿症状,并伴有巨大的膀胱血块潴留。肿瘤被切除,病人接受腹腔镜部分肾切除术。对切除标本进行组织病理学检查,发现肾嗜瘤细胞瘤的典型特征。患者接受导尿管置管,并行膀胱冲洗和血块收回术。
{"title":"High-Resolution Ultrasonography of Renal Oncocytoma Presenting with Symptomatic Hematuria and Urinary Bladder Clot Retention-A Rare Occurrence.","authors":"Reddy Ravikanth","doi":"10.15586/jkcvhl.v9i1.200","DOIUrl":"https://doi.org/10.15586/jkcvhl.v9i1.200","url":null,"abstract":"<p><p>Renal oncocytomas are asymptomatic, benign tumors often encountered incidentally on various imaging modalities. Renal oncocytomas comprise 5-7% of primary renal neoplasms and are derived from cells of the distal renal tubule. We present a case report of renal oncocytoma in a 22-year-old male having right-sided flank pain and symptomatic gross hematuria with a giant urinary bladder clot retention. The tumor was excised, and the patient underwent laparoscopic partial nephrectomy. Typical features of renal oncocytoma were observed upon histopathological examination of the resected specimen. The patient was catheterized, and bladder irrigation with clot retraction was performed.</p>","PeriodicalId":44291,"journal":{"name":"Journal of Kidney Cancer and VHL","volume":"9 1","pages":"15-18"},"PeriodicalIF":1.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39640920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of Kidney Cancer and VHL
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1